Diagnostic Greece / Προϊόντα / Συνεχής καταγραφή γλυκόζης / Βιβλιογραφία
 
ΕΠΙΚΟΙΝΩΝΗΣΤΕ ΜΑΖΙ ΜΑΣ - Sitemap
Greek - English
Greece
Βιβλιογραφία


S. Buscemi et Al.
GLYCEMIC VARIABILITY USING 48-HOUR CONTINUOUS GLUCOSE MONITORING AND ENDOTHELIAL FUNCTION IN THE METABOLIC SYNDROME
Presented at 69th ADA Congress, New Orleans, June 5-9, 2009
Hermanns N. et Al.
SHORT-TERM EFFECTS ON PATIENT SATISFACTION OF CONTINUOUS GLUCOSE MONITORING WITH THE GLUCODAY WITH REAL-TIME AND RETROSPECTIVE ACCESS TO GLUCOSE VALUES: A CROSSOVER STUDY
Diabetes Technology and Therapeutics, 11(5), 275-281, 2009
S. Buscemi et Al.
GLYCAEMIC VARIABILITY AND INFLAMMATION IN SUBJECTS WITH METABOLIC SYNDROME
Acta Diabetologica, 46(1), 55-61, 2009
Marfella et Al.
EFFECTS OF VILDAGLIPTIN TWICE DAILY VS. SITAGLIPTIN ONCE DAILY ON 24-HOUR ACUTE GLUCOSE FLUCTUATIONS
Journal of Diabetes and its Complications, published online March 4, 2009. In press
Kazempour-Ardebili S. et Al.
ASSESSING GLYCAEMIC CONTROL IN MAINTENANCE HAEMODIALYSIS PATIENTS WITH TYPE 2 DIABETES
Presented at 69th ADA Congress, New Orleans, June 5-9, 2009. Diabetes Care, published online February 5, 2009. In press
C. De Block et Al.
MINIMALLY-INVASIVE AND NON-INVASIVE CONTINUOUS GLUCOSE MONITORING SYSTEMS: INDICATIONS, ADVANTAGES, LIMITATIONS AND CLINICAL ASPECTS
Current Diabetes Reviews, 4, 159-168, 2008
J. Hermanides et Al.
NO APPARENT LOCAL EFFECT OF INSULIN ON MICRODIALYSIS CONTINUOUS GLUCOSE MONITORING MEASUREMENTS
Diabetes Care, 31 (6), 1120 – 1122, 2008
B. Kovatchev et Al.
COMPARISON OF THE NUMERICAL AND CLINICAL ACCURACY OF FOUR CONTINUOUS GLUCOSE MONITORS
Diabetes Care, 31 (6), 1160 – 1164, 2008
F. Ricci et Al.
EX VIVO CONTINUOUS GLUCOSE MONITORING WITH MICRODIALYSIS TECHNIQUE: THE EXAMPLE OF GLUCODAY
Sensors Journal, 8(1), 63 – 70, 2008
I.M. Wentholt, J.H. DeVries et Al.
NOCTURNAL HYPOGLYCAEMIA IN TYPE 1 DIABETIC PATIENTS, ASSESSED WITH CONTINUOUS GLUCOSE MONITORING: FREQUENCY, DURATION AND ASSOCIATIONS
Diabetic Medicines, 24, 527-532, 2007
R.J. Manders, L.J. van Loon et Al.
PROTEIN HYDROLYSATE CO-INGESTION DOES NOT MODULATE 24H GLYCEMIC CONTROL IN LONG-STANDING TYPE 2 DIABETES PATIENTS.
European Journal of Clinical Nutrition, 1-6, 2007
F. Ricci, F. Caprio et Al.
TOWARD CONTINUOUS GLUCOSE MONITORING WITH PLANAR MODIFIED BIOSENSORS AND MICRODIALYSIS STUDY OF TEMPERATURE, OXYGEN DEPENDENCE AND IN VIVO EXPERIMENT.
Biosensors and Bioelectronics, 22, 2039, 2007
S.F. Praet, L.J. Van Loon et Al.
INFLUENCE OF ACUTE EXERCISE ON HYPERGLYCEMIA IN INSULIN-TREATED TYPE 2 DIABETES
Medicine & Science in Sports & Exercise, 2037-2044, 2007
T. Kubiak, T. Haak et Al.
MICRODIALYSIS-BASED CONTINUOUS GLUCOSE MONITORING WITH GLUCODAY - CLINICAL PERFORMANCE AND PATIENTS' ACCEPTANCE.
Diabetes Technology & Therapeutics, 8(5), 570-575, 2006
L.J. Van Loon, S.F. Praet et Al.
PROTEIN HYDROLYSATE/LEUCINE CO-INGESTION REDUCES THE PREVALENCE OF HYPERGLYCEMIA IN TYPE 2 DIABETIC PATIENTS
Diabetes Care, 29, 2721-2722, 2006
P. Rossetti, G.B. Bolli et Al.
EVALUATION OF THE ACCURACY OF A MICRODIALYSIS-BASED GLUCOSE SENSOR DURING INSULIN-INDUCED HYPOGLYCEMIA, ITS RECOVERY, AND POST-HYPOGLYCEMIC HYPERGLYCEMIA IN HUMANS
Diabetes Technology & Therapeutics, 8(3), 326-337, 2006
C. De Block, P. Rogiers et Al.
INTENSIVE INSULIN THERAPY IN THE INTENSIVE CARE UNIT ASSESSMENT BY CONTINUOUS GLUCOSE MONITORING
Diabetes Care, 29, 1750–1756, 2006
I. M. Wentholt, J.H. De Vries et Al.
A CRITICAL APPRAISAL OF THE CONTINUOUS GLUCOSE–ERROR GRID ANALYSIS
Diabetes Care, 29, 1805–1811, 2006
I. M. Wentholt et Al.
COMPARISON OF A NEEDLE-TYPE AND A MICRODIALYSIS CONTINUOUS GLUCOSE MONITOR IN TYPE 1 DIABETIC PATIENTS
Diabetes Care, 28, 2871–2876, 2005
E. Standl, L. Heinemann et Al.
CONTINUOUS GLUCOSE MONITORING AS A MEANS OF CHARACTERIZING AND ASSESSING HYPOGLYCAEMIA IN PATIENTS WITH TYPE 1 DIABETES (ABSTRACT. ORIGINAL ARTICLE IN GERMAN)
Diabetes Und Stoffwechsel, 14, 352-357, 2005
B. Manuel-y-Keenoy et Al.
TIME COURSE OF OXIDATIVE STRESS STATUS IN THE POSTPRANDIAL AND POSTABSORPTIVE STATES IN TYPE 1 DIABETES MELLITUS: RELATIONSHIP TO GLUCOSE AND LIPID CHANGES.
J Am Coll Nutr., 24(6), 474-485, 2005
A. Chico
OPTIMIZATION OF CSII TREATMENT BY CONTINUOUS GLUCOSE MONITORING
Av Diabetol, 21, 129-134, 2005
G.Mello et Al.
CORRELATION BETWEEN GLICEMIC PROFILES MEASURED BY CONTINUOUS GLUCOSE MONITORING (GLUCODAY) AND FETAL BODY COMPOSITION IN PREGNANT WOMEN WITH NORMAL GLUCOSE TOLERANCE.
Presented at 5th International ADA Workshop-Conference on Gestational Diabetes, Chicago (USA), November 2005
A. Maran, J.H. De Vries et Al.
ONE POINT VERSUS MULTIPOINT CALIBRATION DURING 48 HOURS OF CONTINUOUS GLUCOSE MONITORING WITH THE GLUCODAY SYSTEM
Presented at 5th Diabetes Technology Meeting, San Francisco (USA), November 2005
C. De Block et Al.
CONTINUOUS GLUCOSE MONITORING IN A MEDICAL INTENSIVE CARE UNIT
Oral Presentation, 41th EASD Congress Athens, Greece, September 2005; Diabetologia, 48 (1), 2005
S. F. E. Praet et Al.
EFFECT OF EXERCISE ON 24HR GLUCOSE PROFILE IN INSULIN-TREATED TYPE 2 DIABETES PATIENTS
Presented at South African Sports Medicine Association (SASMA) Annual Congress. Johannesburg, South Africa, 28 Sept-1 Oct 2005
L. Heinemann
EVALUATION OF THE CONTINUOUS GLUCOSE MONITORING SYSTEM GLUCODAY® IN PATIENTS WITH DIABETES: RESULTS OF A GLUCOSE-CLAMP STUDY WITH RAPID HYPOGLYCEMIC AND HYPERGLYCEMIC EXCURSIONS
Presented at 40th DDG Congress Berlin, Germany, May 2005
B. Costa et Al.
THE RECORD PROJECT. CONTINUOUS BLOOD GLUCOSE MONITORING AMONG HIGH-RISK SUBJECTS FOR DEVELOPING DIABETES IN SPANISH PRIMARY HEALTH CARE
Presented at 1st International Congress on Prediabetes and the Metabolic Sindrome Berlin, Germany, April 2005
F. Ricci, D. Moscone et Al.
NOVEL PLANAR GLUCOSE BIOSENSORS FOR CONTINUOUS MONITORING USE
Biosensors and Bioelectronics, 20, 1993, 2005
A.Maran et Al.
CONTINUOUS GLUCOSE MONITORING IN CONDITIONS OTHER THAN DIABETES
Diabetes Metab Res Rev, 20, S50-S55, 2004
A. Varela et Al.
GLUCOSE CONTINUOUS MONITORING THROUGH A MICRODIALYSIS DEVICE. PRELIMINARY RESULTS
Presented at 12th International Congress of Endocrinology (ICE). Lisbon, Portugal, 31 August-4 September 2004
B. Catargi et Al.
MESURE CONTINUE DE LA GLYCÉMIE PAR MICRODIALYSE COMME OUTIL D’AIDE AU DIAGNOSTIC ET AU TRAITEMENT DES HYPOGLYCÉMIES
Presented at SFE (Congress of the French Society of Endocrinology) Reims, France, September 2004
A.Maran et Al.
ON-LINE GLUCOSE PREDICTION FROM CONTINUOUS MONITORING DATA AND PREVENTION OF HYPER/HYPO-GLYCAEMIC EVENTS
Diabetologia, 47(1), 2004
J.H. De Vries, A. Maran et Al.
NOCTURNAL HYPOGLYCAEMIA IS NOT INEVITABLE IN TYPE 1 DIABETES PATIENTS ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
Presented at 18th IDF Congress Paris, France 24-29 August 2003
G.Dimitriadis, S. A. Raptis et Al.
CONTINUOUS MONITORING OF SUBCUTANEOUS GLUCOSE LEVELS WITH GLUCODAY® : COMPARISON WITH THE REFERENCE HEXOKINASE METHOD AND THE BIOSTATOR®
Presented at 18th IDF Congress Paris, France 24-29 August 2003
J.H. DeVries et Al.
IDENTIFICATION OF ASYMPTOMATIC HYPOGLYCAEMIA IN PATIENTS WITH INSULINOMA WITH CONTINUOUS GLUCOSE MONITORING
23rd Workshop of the Study Group on Artificial Insulin Delivery, Pancreas and Islet Transplantation (AIDPIT) of the EASD. Igls, Austria, January 25-27, 2004. Acta Diabetologica, 40, 196, 2003
E. Esmatjes et Al.
HYPOGLYCAEMIA AFTER PANCREAS TRANSPLANTATION: USEFULNESS OF A CONTINUOUS GLUCOSE MONITORING SYSTEM
Clinical Transpantation, 17, 534-538, 2003
C. Crepaldi et Al.
CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH GLYCOGEN STORAGE DISEASE
Presented at 18th IDF Congress Paris, France 24-29 August 2003
A. Maran et Al.
INSULINOMA DIAGNOSIS:ROLE OF CONTINUOUS SUBCUTANEOUS GLUCOSE MONITORING
Presented at International Diabetes Federation Congress; Paris, France 24-29 August 2003
B.Manuel -y-Keenoy et Al.
TIME COURSE OF OXIDATIVE STRESS STATUS IN THE POSTPRANDIAL AND POSTABSORPTIVE PHASES IN TYPE 1 DIABETES MELLITUS
Presented at 18th IDF Congress; Paris, France 24-29 August 2003. Diabetes Metab Res Rev, 20, S24-S31, 2004
J. DeVries et Al.
NOCTURNAL HYPOGLYCEMIA IS NOT INEVITABLE IN TYPE 1 DIABETES PATIENTS ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
Presented at 63rd ADA Congress, New Orleans, June 13-17, 2003. Diabetes, 52(1), 394, 2003
M. C. Ribaudo et Al.
EFFECTIVENESS OF CONTINUOUS SUBCUTANEOUS GLUCOSE MONITORING IN DIABETIC PATIENTS AFFECTED BY OBESITY
Presented at 18th IDF Congress. Paris, France 24-29 August 2003
D. Moscone et Al.
A MICRODIALYSIS TECHNIQUE FOR CONTINUOUS SUBCUTANEOUS GLUCOSE MONITORING IN DIABETIC PATIENTS (part 1)
Biosensor & Bioelectronics 18, 891-898, 2003
G.Marelli, S.Bistoni et Al.
A MICRODIALYSIS TECHNIQUE FOR CONTINUOUS SUBCUTANEOUS GLUCOSE MONITORING IN DIABETIC PATIENTS (part 2)
Biosensor & Bioelectronics 18, 899-906, 2003
A. Maran and A. Poscia
CONTINUOUS SUBCUTANEOUS GLUCOSE MONITORING: THE GLUCODAY SYSTEM
Diabetes Nutrition and Metabolism, 15, 429-33, 2002